Global Preimplantation Genetic Screening (PGS) Technology Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 43927
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Preimplantation Genetic Screening (PGS) Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Preimplantation Genetic Screening (PGS) Technology size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Preimplantation Genetic Screening (PGS) Technology market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Preimplantation Genetic Screening (PGS) Technology market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Next-generation Sequencing

Polymerase Chain Reaction

Fluorescence in Situ Hybridization

Comparative Genomic Hybridization

Single-nucleotide Polymorphism

Market segment by Application, can be divided into

Maternity Centers & Fertility Clinics

Hospitals

Research Laboratories & Academic Institutes

Others

Market segment by players, this report covers

Illumina

Thermo Fisher Scientific

Agilent Technologies

PerkinElmer

Coopersurgical

Natera

Takara Bio

Oxford Gene Technology

INVICTA

Genea

Progenesis

Igenomix

Reproductive Health and Wellness Center

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Preimplantation Genetic Screening (PGS) Technology

1.2 Classification of Preimplantation Genetic Screening (PGS) Technology by Type

1.2.1 Overview: Global Preimplantation Genetic Screening (PGS) Technology Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type in 2020

1.2.3 Next-generation Sequencing

1.2.4 Polymerase Chain Reaction

1.2.5 Fluorescence in Situ Hybridization

1.2.6 Comparative Genomic Hybridization

1.2.7 Single-nucleotide Polymorphism

1.3 Global Preimplantation Genetic Screening (PGS) Technology Market by Application

1.3.1 Overview: Global Preimplantation Genetic Screening (PGS) Technology Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Maternity Centers & Fertility Clinics

1.3.3 Hospitals

1.3.4 Research Laboratories & Academic Institutes

1.3.5 Others

1.4 Global Preimplantation Genetic Screening (PGS) Technology Market Size & Forecast

1.5 Global Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast by Region

1.5.1 Global Preimplantation Genetic Screening (PGS) Technology Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Preimplantation Genetic Screening (PGS) Technology Market Size by Region, (2016-2021)

1.5.3 North America Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2016-2026)

1.5.4 Europe Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2016-2026)

1.5.6 South America Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Preimplantation Genetic Screening (PGS) Technology Market Drivers

1.6.2 Preimplantation Genetic Screening (PGS) Technology Market Restraints

1.6.3 Preimplantation Genetic Screening (PGS) Technology Trends Analysis

2 Company Profiles

2.1 Illumina

2.1.1 Illumina Details

2.1.2 Illumina Major Business

2.1.3 Illumina Preimplantation Genetic Screening (PGS) Technology Product and Solutions

2.1.4 Illumina Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Illumina Recent Developments and Future Plans

2.2 Thermo Fisher Scientific

2.2.1 Thermo Fisher Scientific Details

2.2.2 Thermo Fisher Scientific Major Business

2.2.3 Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Product and Solutions

2.2.4 Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.3 Agilent Technologies

2.3.1 Agilent Technologies Details

2.3.2 Agilent Technologies Major Business

2.3.3 Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Product and Solutions

2.3.4 Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Agilent Technologies Recent Developments and Future Plans

2.4 PerkinElmer

2.4.1 PerkinElmer Details

2.4.2 PerkinElmer Major Business

2.4.3 PerkinElmer Preimplantation Genetic Screening (PGS) Technology Product and Solutions

2.4.4 PerkinElmer Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 PerkinElmer Recent Developments and Future Plans

2.5 Coopersurgical

2.5.1 Coopersurgical Details

2.5.2 Coopersurgical Major Business

2.5.3 Coopersurgical Preimplantation Genetic Screening (PGS) Technology Product and Solutions

2.5.4 Coopersurgical Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Coopersurgical Recent Developments and Future Plans

2.6 Natera

2.6.1 Natera Details

2.6.2 Natera Major Business

2.6.3 Natera Preimplantation Genetic Screening (PGS) Technology Product and Solutions

2.6.4 Natera Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Natera Recent Developments and Future Plans

2.7 Takara Bio

2.7.1 Takara Bio Details

2.7.2 Takara Bio Major Business

2.7.3 Takara Bio Preimplantation Genetic Screening (PGS) Technology Product and Solutions

2.7.4 Takara Bio Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Takara Bio Recent Developments and Future Plans

2.8 Oxford Gene Technology

2.8.1 Oxford Gene Technology Details

2.8.2 Oxford Gene Technology Major Business

2.8.3 Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Product and Solutions

2.8.4 Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Oxford Gene Technology Recent Developments and Future Plans

2.9 INVICTA

2.9.1 INVICTA Details

2.9.2 INVICTA Major Business

2.9.3 INVICTA Preimplantation Genetic Screening (PGS) Technology Product and Solutions

2.9.4 INVICTA Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 INVICTA Recent Developments and Future Plans

2.10 Genea

2.10.1 Genea Details

2.10.2 Genea Major Business

2.10.3 Genea Preimplantation Genetic Screening (PGS) Technology Product and Solutions

2.10.4 Genea Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Genea Recent Developments and Future Plans

2.11 Progenesis

2.11.1 Progenesis Details

2.11.2 Progenesis Major Business

2.11.3 Progenesis Preimplantation Genetic Screening (PGS) Technology Product and Solutions

2.11.4 Progenesis Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Progenesis Recent Developments and Future Plans

2.12 Igenomix

2.12.1 Igenomix Details

2.12.2 Igenomix Major Business

2.12.3 Igenomix Preimplantation Genetic Screening (PGS) Technology Product and Solutions

2.12.4 Igenomix Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Igenomix Recent Developments and Future Plans

2.13 Reproductive Health and Wellness Center

2.13.1 Reproductive Health and Wellness Center Details

2.13.2 Reproductive Health and Wellness Center Major Business

2.13.3 Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Product and Solutions

2.13.4 Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Reproductive Health and Wellness Center Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Preimplantation Genetic Screening (PGS) Technology Players Market Share

3.2.2 Top 10 Preimplantation Genetic Screening (PGS) Technology Players Market Share

3.2.3 Market Competition Trend

3.3 Preimplantation Genetic Screening (PGS) Technology Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue and Market Share by Type (2016-2021)

4.2 Global Preimplantation Genetic Screening (PGS) Technology Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application (2016-2021)

5.2 Preimplantation Genetic Screening (PGS) Technology Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2016-2026)

6.2 North America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2016-2026)

6.3 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country

6.3.1 North America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2016-2026)

6.3.2 United States Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

6.3.3 Canada Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

6.3.4 Mexico Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2016-2026)

7.2 Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2016-2026)

7.3 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country

7.3.1 Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2016-2026)

7.3.2 Germany Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

7.3.3 France Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

7.3.5 Russia Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

7.3.6 Italy Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2016-2026)

8.2 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2016-2026)

8.3 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region

8.3.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Region (2016-2026)

8.3.2 China Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

8.3.3 Japan Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

8.3.4 South Korea Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

8.3.5 India Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

8.3.7 Australia Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2016-2026)

9.2 South America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2016-2026)

9.3 South America Preimplantation Genetic Screening (PGS) Technology Market Size by Country

9.3.1 South America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2016-2026)

9.3.2 Brazil Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

9.3.3 Argentina Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2016-2026)

10.2 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2016-2026)

10.3 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country

10.3.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2016-2026)

10.3.2 Turkey Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

10.3.4 UAE Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Preimplantation Genetic Screening (PGS) Technology Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Preimplantation Genetic Screening (PGS) Technology Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) by Region (2016-2021)

Table 5. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Region (2021-2026)

Table 6. Illumina Corporate Information, Head Office, and Major Competitors

Table 7. Illumina Major Business

Table 8. Illumina Preimplantation Genetic Screening (PGS) Technology Product and Solutions

Table 9. Illumina Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 11. Thermo Fisher Scientific Major Business

Table 12. Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Product and Solutions

Table 13. Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Agilent Technologies Corporate Information, Head Office, and Major Competitors

Table 15. Agilent Technologies Major Business

Table 16. Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Product and Solutions

Table 17. Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. PerkinElmer Corporate Information, Head Office, and Major Competitors

Table 19. PerkinElmer Major Business

Table 20. PerkinElmer Preimplantation Genetic Screening (PGS) Technology Product and Solutions

Table 21. PerkinElmer Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Coopersurgical Corporate Information, Head Office, and Major Competitors

Table 23. Coopersurgical Major Business

Table 24. Coopersurgical Preimplantation Genetic Screening (PGS) Technology Product and Solutions

Table 25. Coopersurgical Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Natera Corporate Information, Head Office, and Major Competitors

Table 27. Natera Major Business

Table 28. Natera Preimplantation Genetic Screening (PGS) Technology Product and Solutions

Table 29. Natera Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Takara Bio Corporate Information, Head Office, and Major Competitors

Table 31. Takara Bio Major Business

Table 32. Takara Bio Preimplantation Genetic Screening (PGS) Technology Product and Solutions

Table 33. Takara Bio Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Oxford Gene Technology Corporate Information, Head Office, and Major Competitors

Table 35. Oxford Gene Technology Major Business

Table 36. Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Product and Solutions

Table 37. Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. INVICTA Corporate Information, Head Office, and Major Competitors

Table 39. INVICTA Major Business

Table 40. INVICTA Preimplantation Genetic Screening (PGS) Technology Product and Solutions

Table 41. INVICTA Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Genea Corporate Information, Head Office, and Major Competitors

Table 43. Genea Major Business

Table 44. Genea Preimplantation Genetic Screening (PGS) Technology Product and Solutions

Table 45. Genea Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Progenesis Corporate Information, Head Office, and Major Competitors

Table 47. Progenesis Major Business

Table 48. Progenesis Preimplantation Genetic Screening (PGS) Technology Product and Solutions

Table 49. Progenesis Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Igenomix Corporate Information, Head Office, and Major Competitors

Table 51. Igenomix Major Business

Table 52. Igenomix Preimplantation Genetic Screening (PGS) Technology Product and Solutions

Table 53. Igenomix Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Reproductive Health and Wellness Center Corporate Information, Head Office, and Major Competitors

Table 55. Reproductive Health and Wellness Center Major Business

Table 56. Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Product and Solutions

Table 57. Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Global Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) by Players (2019-2021)

Table 59. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Players (2019-2021)

Table 60. Breakdown of Preimplantation Genetic Screening (PGS) Technology by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Preimplantation Genetic Screening (PGS) Technology Players Head Office, Products and Services Provided

Table 62. Preimplantation Genetic Screening (PGS) Technology Mergers & Acquisitions in the Past Five Years

Table 63. Preimplantation Genetic Screening (PGS) Technology New Entrants and Expansion Plans

Table 64. Global Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) by Type (2016-2021)

Table 65. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Type (2016-2021)

Table 66. Global Preimplantation Genetic Screening (PGS) Technology Revenue Forecast by Type (2021-2026)

Table 67. Global Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2016-2021)

Table 68. Global Preimplantation Genetic Screening (PGS) Technology Revenue Forecast by Application (2021-2026)

Table 69. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2016-2021) & (USD Million)

Table 70. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2021-2026) & (USD Million)

Table 71. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2016-2021) & (USD Million)

Table 72. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2021-2026) & (USD Million)

Table 73. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2016-2021) & (USD Million)

Table 74. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2021-2026) & (USD Million)

Table 75. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2016-2021) & (USD Million)

Table 76. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2021-2026) & (USD Million)

Table 77. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2016-2021) & (USD Million)

Table 78. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2021-2026) & (USD Million)

Table 79. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2016-2021) & (USD Million)

Table 80. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2021-2026) & (USD Million)

Table 81. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2016-2021) & (USD Million)

Table 82. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2021-2026) & (USD Million)

Table 83. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2016-2021) & (USD Million)

Table 84. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2021-2026) & (USD Million)

Table 85. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Region (2016-2021) & (USD Million)

Table 86. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Region (2021-2026) & (USD Million)

Table 87. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2016-2021) & (USD Million)

Table 88. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2021-2026) & (USD Million)

Table 89. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2016-2021) & (USD Million)

Table 90. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2021-2026) & (USD Million)

Table 91. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2016-2021) & (USD Million)

Table 92. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2021-2026) & (USD Million)

Table 93. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2016-2021) & (USD Million)

Table 94. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2021-2026) & (USD Million)

Table 95. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2016-2021) & (USD Million)

Table 96. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2021-2026) & (USD Million)

Table 97. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2016-2021) & (USD Million)

Table 98. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Preimplantation Genetic Screening (PGS) Technology Picture

Figure 2. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type in 2020

Figure 3. Next-generation Sequencing

Figure 4. Polymerase Chain Reaction

Figure 5. Fluorescence in Situ Hybridization

Figure 6. Comparative Genomic Hybridization

Figure 7. Single-nucleotide Polymorphism

Figure 8. Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application in 2020

Figure 9. Maternity Centers & Fertility Clinics Picture

Figure 10. Hospitals Picture

Figure 11. Research Laboratories & Academic Institutes Picture

Figure 12. Others Picture

Figure 13. Global Preimplantation Genetic Screening (PGS) Technology Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 14. Global Preimplantation Genetic Screening (PGS) Technology Revenue and Forecast (2016-2026) & (USD Million)

Figure 15. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Region (2016-2026)

Figure 16. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Region in 2020

Figure 17. North America Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Europe Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. South America Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Preimplantation Genetic Screening (PGS) Technology Market Drivers

Figure 23. Preimplantation Genetic Screening (PGS) Technology Market Restraints

Figure 24. Preimplantation Genetic Screening (PGS) Technology Market Trends

Figure 25. Illumina Recent Developments and Future Plans

Figure 26. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 27. Agilent Technologies Recent Developments and Future Plans

Figure 28. PerkinElmer Recent Developments and Future Plans

Figure 29. Coopersurgical Recent Developments and Future Plans

Figure 30. Natera Recent Developments and Future Plans

Figure 31. Takara Bio Recent Developments and Future Plans

Figure 32. Oxford Gene Technology Recent Developments and Future Plans

Figure 33. INVICTA Recent Developments and Future Plans

Figure 34. Genea Recent Developments and Future Plans

Figure 35. Progenesis Recent Developments and Future Plans

Figure 36. Igenomix Recent Developments and Future Plans

Figure 37. Reproductive Health and Wellness Center Recent Developments and Future Plans

Figure 38. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Players in 2020

Figure 39. Preimplantation Genetic Screening (PGS) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 40. Global Top 3 Players Preimplantation Genetic Screening (PGS) Technology Revenue Market Share in 2020

Figure 41. Global Top 10 Players Preimplantation Genetic Screening (PGS) Technology Revenue Market Share in 2020

Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 43. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Type in 2020

Figure 44. Global Preimplantation Genetic Screening (PGS) Technology Market Share Forecast by Type (2021-2026)

Figure 45. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Application in 2020

Figure 46. Global Preimplantation Genetic Screening (PGS) Technology Market Share Forecast by Application (2021-2026)

Figure 47. North America Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2016-2026)

Figure 48. North America Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2016-2026)

Figure 49. North America Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Country (2016-2026)

Figure 50. United States Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Canada Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Mexico Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Europe Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2016-2026)

Figure 54. Europe Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2016-2026)

Figure 55. Europe Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Country (2016-2026)

Figure 56. Germany Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. France Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. United Kingdom Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Russia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Italy Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2016-2026)

Figure 62. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2016-2026)

Figure 63. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Region (2016-2026)

Figure 64. China Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Japan Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. South Korea Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. India Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Southeast Asia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Australia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. South America Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2016-2026)

Figure 71. South America Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2016-2026)

Figure 72. South America Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Country (2016-2026)

Figure 73. Brazil Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Argentina Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2016-2026)

Figure 76. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2016-2026)

Figure 77. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Country (2016-2026)

Figure 78. Turkey Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Saudi Arabia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. UAE Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Methodology

Figure 82. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz